Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07763561

EUS-DFI in Solid Pancreatic Lesions

This prospective, international, multicenter observational study aims to evaluate the role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) in the characterization of solid pancreatic lesions. The study will assess microvascularization patterns identified by EUS-DFI and their association with the final diagnosis, using histopathology or clinical follow-up as the reference standard. Secondary objectives include evaluating interobserver agreement and the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant pancreatic lesions.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Endoscopic ultrasound (EUS) is an essential technique for the evaluation of pancreatic lesions. However, conventional B-mode imaging alone is often insufficient to accurately differentiate the various types of solid pancreatic tumors, making tissue acquisition necessary in many cases. Despite the high diagnostic accuracy of EUS-guided sampling, false-negative results may occur and repeated sampling can be required.

Detective Flow Imaging (DFI) is a novel ultrasound technology that enables visualization of microvascularization without the use of contrast agents by detecting low-velocity blood flow while minimizing motion artifacts. Preliminary evidence suggests that DFI may improve lesion characterization, but data regarding its application in solid pancreatic lesions remain limited.

This is a prospective, international, multicenter observational study including adult patients undergoing routine EUS in whom a solid pancreatic lesion is identified. All participants will undergo standard EUS evaluation, EUS-guided DFI assessment, and tissue acquisition according to routine clinical practice. DFI findings will be correlated with the final diagnosis established by surgical pathology, EUS-guided tissue sampling, or comprehensive clinical, imaging, and laboratory follow-up of at least six months.

The primary objective is to characterize DFI microvascularization patterns according to the histological diagnosis of solid pancreatic lesions. Secondary objectives include assessing interobserver agreement among investigators and determining the diagnostic performance of DFI vascular patterns for differentiating malignant from benign pancreatic lesions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older.
  • Presence of a solid pancreatic lesion identified during endoscopic ultrasound (EUS), regardless of the indication for the examination.
  • Ability and willingness to provide written informed consent.

Exclusion criteria

  • Predominantly cystic pancreatic lesions.
  • Anatomical abnormalities preventing adequate EUS examination.
  • Limited ability to understand the study procedures or provide informed consent.
  • Refusal to sign the informed consent form.

Treatment and study plan

Primary outcomes

  1. DFI vascularization pattern

    Time frame: At the time of the EUS procedure

    Classification of vascularization pattern as hypovascular, isovascular, hypervascular or indeterminate on DFI.

  2. Presence of vessels

    Time frame: At the time of the EUS procedure

    Presence or absence of vessels identified on DFI.

  3. Vessel distribution

    Time frame: At the time of the EUS procedure

    Classification of vessel distribution as intratumoral or peritumoral on DFI.

Secondary outcomes

  1. Interobserver agreement for DFI vascular pattern classification

    Time frame: Up to 6 months

    To assess the interobserver agreement among investigators for the classification of DFI vascular patterns.

  2. Diagnostic accuracy of DFI vascular patterns for malignancy

    Time frame: Up to 6 months

    To evaluate the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant solid pancreatic lesions using the final diagnosis as the reference standard.

Study contacts

Contact information is provided by the study sponsor or research team.

Julio Iglesias García, PhD

CONTACT

[email protected]

981951364 ext. +34

Sponsors and collaborators

Lead sponsor

Julio Iglesias García

Other

Collaborators

  • Leids Universitair Medisch Centrum (LUMC), Leiden
  • Ospedale San Raffaele, Università Vita Salute San Raffaele
  • Policlinico Universitario Campus Bio-Medico

Registry information

Official study title

Role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) for the Evaluation of Solid Pancreatic Tumours: A Prospective, International Multicenter Study

Acronym: DFI

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 13, 2026
Registry last updated
Aug 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.